Perdiquez, Baby Girl .
HRN: 22-54-60 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/27/2023
02/03/2023
IV
42 Mg
Q24
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes